Suppr超能文献

lncRNA SNHG9 通过招募 EZH2 负调控 PTEN 表达增强肝癌干细胞自我更新和致瘤性。

lncRNA SNHG9 enhances liver cancer stem cell self-renewal and tumorigenicity by negatively regulating PTEN expression via recruiting EZH2.

机构信息

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical University, Nan Bai Xiang Street, Ouhai District, Wenzhou, 325000, China.

Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.

出版信息

Cell Tissue Res. 2023 Dec;394(3):441-453. doi: 10.1007/s00441-023-03834-x. Epub 2023 Oct 18.

Abstract

Liver cancer stem cell (CSC) self-renewal and tumorigenesis are important causes of hepatocellular carcinoma (HCC) recurrence. We purposed to investigate the function of long noncoding RNA small nucleolar RNA host gene 9 (SNHG9) in liver CSC self-renewal and tumorigenesis in this study. Flow cytometry was carried out to separate CD133 Populations and CD133 Populations from HCC cell lines. A combination of CD133 cells and Matrigel matrix was subcutaneously injected to create the NOD-SCID mouse xenograft tumor model. Colony formation test and spheroids formation assay were carried out to clarify the impact of SNHG9 on the self-renewal of liver CSCs. RNA immunoprecipitation, RNA-pull down, and chromatin immunoprecipitation were performed on CD133 cells to elucidate the mechanism of SNHG9 regulating PTEN expression. We found that SNHG9 was highly expressed in HCC clinical samples, HCC cells, and CD133 cells. In vitro, interference with SNHG9 prevented the formation of colonies and spheroids in liver CSC cells and primary HCC cells. In vivo, interference with SNHG9 reduced the tumor volume and weight. SNHG9 could bind to EZH2, and SNHG9 interference suppressed EZH2 recruitment and H3K27me3 levels in the PTEN promoter region. In addition, SNHG9 inhibition promoted PTEN expression while having little impact on EZH2 levels. Interference with SNHG9 inhibited liver CSC self-renewal and tumorigenesis by up-regulating PTEN levels. In conclusion, by binding to EZH2, SNHG9 down-regulated PTEN levels, promoting liver CSC self-renewal and tumor formation, and exacerbating HCC progression.

摘要

肝癌干细胞(CSC)自我更新和致瘤是肝细胞癌(HCC)复发的重要原因。本研究旨在探讨长链非编码 RNA 小核仁 RNA 宿主基因 9(SNHG9)在肝 CSC 自我更新和致瘤中的作用。通过流式细胞术分离 HCC 细胞系中的 CD133+细胞群和 CD133-细胞群。将 CD133 细胞与 Matrigel 基质混合,皮下注射建立 NOD-SCID 小鼠异种移植肿瘤模型。集落形成试验和球体形成试验阐明 SNHG9 对肝 CSCs 自我更新的影响。在 CD133 细胞中进行 RNA 免疫沉淀、RNA 下拉和染色质免疫沉淀,以阐明 SNHG9 调节 PTEN 表达的机制。我们发现 SNHG9 在 HCC 临床样本、HCC 细胞和 CD133 细胞中高表达。体外,干扰 SNHG9 可阻止肝 CSC 细胞和原代 HCC 细胞集落和球体的形成。体内,干扰 SNHG9 可减少肿瘤体积和重量。SNHG9 可与 EZH2 结合,干扰 SNHG9 可抑制 EZH2 在 PTEN 启动子区域的募集和 H3K27me3 水平。此外,SNHG9 抑制作用可通过上调 PTEN 水平而对 EZH2 水平影响不大。干扰 SNHG9 通过上调 PTEN 水平抑制肝 CSC 自我更新和致瘤作用。总之,SNHG9 通过与 EZH2 结合,下调 PTEN 水平,促进肝 CSC 自我更新和肿瘤形成,加剧 HCC 进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验